Sunwin International Neutraceuticals in Agreement to Supply Stevia Extracts to Domino Foods

QUFU, China, Dec. 6, 2011 /PRNewswire/ -- Sunwin International Neutraceuticals, Inc. "Sunwin International" (OTC.BB:SUWN), one of the top global providers of high quality stevia extracts including Rebaudioside A 98, announced today that it has entered into an agreement to supply its stevia extracts to Domino Foods, Inc. and its affiliated companies for use in low calorie sweetners it recently developed and distributes.

In May of 2011, Sunwin International, Domino Foods and Wild Flavors jointly announced an agreement to partner in an unprecedented fashion to focus their company's efforts to introduce a wide range of all natural, low calorie and no calorie sweetening solutions that contain Sunwin Stevia™.  This new supply agreement will enable Sunwin to provide a wide range of its FDA GRAS affirmed stevia extracts to Domino for use in products such as "Domino Lite", an exciting new lower calorie blend of sugar and stevia now available in the United States.  In addition, it will enable Domino Foods to offer Sunwin's stevia extracts and sweetening solutions made with Sunwin Stevia™ to its extensive network of food and beverage industry clients in North America and Europe.

Commenting on the supply agreement, Ms.Dongdong Lin, CEO of Sunwin International, stated "We are excited to further our relationship with Domino Foods through this new agreement.  As we have worked very hard to develop stevia extracts that are consistent in taste and quality for the food and beverage industry, having a company like Domino recognize that effort by choosing Sunwin as a supplier is a significant milestone for Sunwin.  Domino Foods is one of the largest and most well respected companies in this industry and we intend to supply the highest quality stevia extracts as their trusted supplier in order to build a long lasting partnership in order to capitalize on the growing use of Stevia as a sweetener across the globe."

Brian O'Malley, President & CEO of Domino Foods commented "We are quite confident that Sunwin International can provide us with the highest quality stevia extracts and we look forward to bringing this all natural sweetener alternative to our customers."

The agreement was reached with the assistance of China Direct Investments, Inc., a subsidiary of China Direct Industries, Inc. (NASDAQ: CDII), which provides corporate and management advisory services to Sunwin International and acted as an intermediary between the two parties on Sunwin's behalf.

About Domino Foods, Inc.

Headquartered in Iselin, NJ, Domino Foods, Inc. is the largest marketer of refined sugar in the U.S. The company is responsible for the sales, marketing and logistics (including the order to cash cycle) for the output of the American Sugar Refining, Inc., C&H Sugar Company, Inc.,  and Okeelanta Corporation (a subsidiary of Florida Crystals Corporation). The company sells through five distribution channels (Industrial, Grocery, Foodservice, Specialty and Export). Products are sold with the following trademarks --Domino®, C&H® and Florida Crystals®.

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc. engages in the areas of essential traditional Chinese medicine and zero calorie natural sweeteners (Sunwin Stevia™ Extracts). As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. For more info about Sunwin, please visit http://www.sunwininternational.com.

Contact:

Lillian Wong
U.S. Representative
954-363-7333
[email protected]

Sunwin International Neutraceuticals, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our expectations regarding our relationship with Domino Foods and sales under the supply agreement.

We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2011.

SOURCE Sunwin International Neutraceuticals, Inc.